Evidence map›Paper›PMID 38288046›Full record

ArticleHealth affairs scholar2023

Methadone prescribing by addiction specialists likely to leave communities without available methadone treatment.

Paul J Joudrey, Dylan Halpern, Qinyun Lin, Susan Paykin, Christina Mair, Marynia Kolak

Open access · diamondAbstract read
In one paragraph

Article in Health affairs scholar, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Paul J JoudreyCenter for Research on Health Care, Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA 15213, United States.ORCID 0000-0001-6448-1526
Dylan HalpernData Science Institute, University of Chicago, Chicago, IL 60637, United States.ORCID 0000-0002-9766-6065
Qinyun LinInstitute of Medicine, University of Gothenburg, Gothenburg 413 46, Sweden.ORCID 0000-0001-9792-3351
Susan PaykinData Science Institute, University of Chicago, Chicago, IL 60637, United States.ORCID 0000-0002-3340-1308
Christina MairDepartment of Behavioral and Community Health Sciences, University of Pittsburgh School of Public Health, Pittsburgh, PA 15261, United States.
Marynia KolakDepartment of Geography and Geographic Information Science, University of Illinois, Urbana, IL 61801, United States.ORCID 0000-0001-6070-9167
University of Chicago · USUniversity of Pittsburgh · USUniversity of Gothenburg · SEUniversity of Illinois Urbana-Champaign · US

Funding

Survey CoreU2CDA050098 · NIDA · UNIVERSITY OF CHICAGO · PI POLLACK, HAROLD ALEXANDER, SCHNEIDER, JOHN · 2019 to 2019
$17.2M
Yale Drug use, Addiction and HIV Research Scholars (DAHRS)K12DA033312 · NIDA · YALE UNIVERSITY · PI Gail D'Onofrio, Patrick O'Connor · 2013 to 2026
$7.2M
NIDA NIH HHS K12 DA033312NIDA NIH HHS U2C DA050098
6 · The paper itself

Abstract

Methadone treatment for opioid use disorder is not available in most suburban and rural US communities. We examined 2 options to expand methadone availability: (1) addiction specialty physician or (2) all clinician prescribing. Using 2022 Health Resources and Services Administration data, we used mental health professional shortage areas to indicate the potential of addiction specialty physician prescribing and the location of federally qualified health centers (ie, federally certified primary care clinics) to indicate the potential of all clinician prescribing. We examined how many census tracts without an available opioid treatment program (ie, methadone clinic) are (1) located within a mental health professional shortage area and (2) are also without an available federally qualified health center. Methadone was available in 49% of tracts under current regulations, 63% of tracts in the case of specialist physician prescribing, and 86% of tracts in the case of all clinician prescribing. Specialist physician prescribing would expand availability to an additional 12% of urban, 18% of suburban, and 16% of rural tracts, while clinician prescribing would expand to an additional 30% of urban, 53% of suburban, and 58% of rural tracts relative to current availability. Results support enabling broader methadone prescribing privileges to ensure equitable treatment access, particularly for rural communities.

Indexed as

accessmethadoneopioid use disorderrural

Identifiers

PMID38288046
PMCPMC10824529
OpenAlexW4388522822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.